

Bcl-B Antibody (3B4) is a mouse monoclonal IgG2b kappa light chain antibody that detects the Bcl-B protein of human origin by western blotting (WB), immunoprecipitation (IP), and enzyme-linked immunosorbent assay (ELISA). Anti-Bcl-B antibody (3B4) is available as the non-conjugated format. Bcl-B, also known as BCL2L10, Diva, Boo, or BCLB, is a crucial member of the Bcl-2 family of proteins, consisting of 194 amino acids and widely expressed in various tissues. Bcl-B (3B4) antibody recognizes a protein that plays a vital role in regulating cell survival by inhibiting apoptosis, which is essential for maintaining cellular homeostasis and preventing excessive cell death. Bcl-B is localized to the nuclear membrane, where Bcl-B (3B4) monoclonal antibody detects its anti-apoptotic effects in suppressing BAX-induced apoptosis. Bcl-B contains a BH4 domain and a transmembrane domain, both critical for its function in promoting cell survival. Notably, overexpression of Bcl-B has been linked to the prevention of cytochrome C release from the mitochondria, a key event that triggers caspase-3 activation and leads to apoptosis. Furthermore, Bcl-B is implicated in the pathogenesis of cervical cancer, highlighting its significance in cancer biology and potential as a therapeutic target.
Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA
LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Bcl-B Antibody (3B4) | sc-134279 | 100 µg/ml | $339.00 |